Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
Titel:
Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
Auteur:
Nicolau, Jose Carlos Bhatt, Deepak L. Roe, Matthew T. Lokhnygina, Yuliya Neely, Benjamin Corbalán, Ramón Leiva-Pons, José L. Martinez, Felipe Goodman, Shaun G. Winters, Kenneth J. Verheugt, Freek W.A. Armstrong, Paul W. White, Harvey D. Fox, Keith A.A. Prabhakaran, Dorairaj Ohman, E. Magnus